Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
04/11/2012 | CN102413832A Method of reducing intraocular pressure in humans |
04/11/2012 | CN102408975A Health care sake |
04/11/2012 | CN102408411A Hydroximic acid compound containing quinolyl and preparation method thereof, and drug composition containing the compound and use thereof |
04/11/2012 | CN102406934A 一种鸡传染性鼻炎类脂灭活疫苗的制备方法 Preparation method of infectious coryza lipid inactivated vaccine |
04/11/2012 | CN102406845A 一种治疗角膜溃疡的中药组合物 A method of treating corneal ulcer medicine composition |
04/11/2012 | CN102406751A 一种治疗黄风内障的中药组合物 A yellow wind barrier treatment of traditional Chinese medicine composition |
04/11/2012 | CN102406750A 一种治疗暴风客热的中药组合物 A method of treating storm off the hot herbal composition |
04/11/2012 | CN102406728A Medicinal composition for treating lymphaden inflammations |
04/11/2012 | CN102406692A 治疗口腔白塞氏病的中药组合物及其制法 Behcet's disease treatment of oral Chinese medicine composition and its preparation method |
04/11/2012 | CN102405935A 鱼精蛋白复配制剂及其制备方法和应用 Protamine complex and its preparation method and application |
04/11/2012 | CN101716200B 一种活血通脉、清热解毒的药物组合物及其制备方法和应用 One kind Huoxuetongmai, detoxification of the pharmaceutical composition and its preparation method and application |
04/11/2012 | CN101199659B 一种治疗急性结膜炎的内服中药 A method of treating acute conjunctivitis internal medicine |
04/10/2012 | US8153806 Synthesis of 4-amino-thalidomide enantiomers |
04/10/2012 | US8153673 Metalloproteinase inhibitors |
04/10/2012 | CA2660167C Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases |
04/10/2012 | CA2486663C Method of treating rosacea by topical application of a cyclohexane derivative |
04/10/2012 | CA2477241C Compositions and methods for treating epithelial and retinal tissue diseases |
04/10/2012 | CA2445408C Quinolone carboxylic acid compositions and related methods of treatment |
04/05/2012 | WO2012043891A1 Agent for treatment of eye diseases |
04/05/2012 | WO2012043185A1 Composition for inhibiting il-8 expression |
04/05/2012 | WO2012024419A3 Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma |
04/05/2012 | US20120083772 Corneal treatment system and method |
04/05/2012 | US20120083502 Heterocyclic compounds and their uses |
04/05/2012 | US20120083479 Compositions Comprising Azelastine and Methods of Use Thereof |
04/05/2012 | US20120083476 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase |
04/05/2012 | US20120083474 Heterocyclic amides as modulators of trpa1 |
04/05/2012 | US20120082686 Neovascular-Targeted Immunoconjugates |
04/05/2012 | US20120082635 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors |
04/05/2012 | US20120082627 Otic foam formulations |
04/04/2012 | EP2436675A1 Novel -phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same |
04/04/2012 | EP2435412A1 Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate |
04/04/2012 | EP2435075A2 Antigen-binding proteins |
04/04/2012 | EP1990343B1 Azaindoles |
04/04/2012 | EP1778619B1 T type calcium channel inhibitors |
04/04/2012 | CN1602199B Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
04/04/2012 | CN102397463A 一种用中草药治疗眼疾玻璃体混浊的方法 An eye vitreous opacities with herbal treatment methods |
04/04/2012 | CN102397429A 一种治疗白内障的中药组合物 A method of treating cataract herbal composition |
04/04/2012 | CN102397384A 一种鱼腥草滴眼液及其制备方法 One kind of eye drops and its preparation method Yuxingcao |
04/04/2012 | CN102396935A 一种保健柳丝草席 A health Stir mats |
04/04/2012 | CN101675939B 一种治疗眼角膜炎的中药滴眼液 A method of treating ocular keratitis medicine drops |
04/04/2012 | CN101669901B 用于眼部给药的液体制剂及其制备方法 Liquid and its preparation method for ocular administration |
04/03/2012 | US8148525 2,4-pyrimidinediamine compounds and their uses |
04/03/2012 | US8148429 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
04/03/2012 | US8148125 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
04/03/2012 | CA2582316C Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
04/03/2012 | CA2467759C Use of nanoparticles as carriers for biocides in ophthalmic compositions |
03/29/2012 | WO2012038512A2 Composition comprising sod, lutein and zeaxanthin |
03/29/2012 | WO2012037782A1 Tricyclic compounds, preparation methods, and their uses |
03/29/2012 | US20120077883 Treatment of tinnitus and associated auditory dysfunctions |
03/29/2012 | US20120077870 Materials and Methods for the Treatment of Pathological Neovascularization in the Eye |
03/29/2012 | US20120077864 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions |
03/29/2012 | US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
03/29/2012 | US20120077854 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4) |
03/29/2012 | US20120077840 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
03/29/2012 | US20120077830 Caspase inhibitors and uses thereof |
03/29/2012 | US20120077828 Chemical compounds |
03/29/2012 | US20120077826 [6,5] - bicyclic gpr119 g protein-coupled receptor agonists |
03/29/2012 | US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors |
03/29/2012 | US20120077787 Organic compounds |
03/29/2012 | US20120077769 Topical ophthalmic compositions containing tobramycin and dexamethasone |
03/29/2012 | US20120077763 METHODS FOR TREATING HEART FAILURE BY INHIBITING THE MITOCHONDRIAL SODIUM-CALCIUM EXCHANGER (mNCE) |
03/29/2012 | US20120077756 Methods, compositions, and kits for the treatment of ophthalmic disorders |
03/29/2012 | US20120076848 Method and system for effecting changes in pigmented tissue |
03/29/2012 | US20120076787 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye |
03/29/2012 | CA2812999A1 Composition comprising sod, lutein and zeaxanthin |
03/28/2012 | EP2432475A1 A3 adenosine receptor agonists for the reduction of intraocular pressure |
03/28/2012 | EP2432472A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors |
03/28/2012 | EP2186529B1 Synergic pharmaceutical composition, useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animal |
03/28/2012 | EP1472234B1 Quinazolinone derivatives and their use as cb agonists |
03/28/2012 | EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
03/28/2012 | CN102395589A Fused pyrrolopyridine derivative |
03/28/2012 | CN102395401A Drug delivery through hydrogel plugs |
03/28/2012 | CN102395364A Pharmaceutical compositions |
03/28/2012 | CN102391095A Rheum emodin derivative and application thereof |
03/28/2012 | CN102389500A Heat clearing and detoxifying oral solution |
03/28/2012 | CN102389488A Traditional Chinese medicine for curing diabetic retinopathy |
03/28/2012 | CN102389433A Pharmaceutical composition and compound preparation thereof |
03/28/2012 | CN102389412A Eye drops for treating cataract |
03/28/2012 | CN102389411A Application of gallic acid to preparation of phosphodiesterase inhibitor anti inflammatory medicine |
03/28/2012 | CN102389392A Recombinant bovine basic fibroblast growth factor gel for eye use |
03/28/2012 | CN102389234A Myrica rubra kernel health care mattress |
03/28/2012 | CN102028757B Processing method of mulberry composite extract |
03/28/2012 | CN102018736B Natural indigo decoction piece and preparation method thereof |
03/28/2012 | CN101797348B Traditional Chinese medicine for treating proliferative vitreoretinopathy |
03/28/2012 | CN101747425B Protein relevant to retina photoreaction as well as coding gene and applications thereof |
03/28/2012 | CN101537087B Traditional Chinese medicine composition for treating retinal vein obstruction |
03/27/2012 | US8143312 Transparent eye drops containing latanoprost |
03/27/2012 | US8143291 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity |
03/27/2012 | CA2606370C Self-preserved aqueous pharmaceutical compositions |
03/27/2012 | CA2489862C Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
03/27/2012 | CA2329250C Peptide antiangiogenic drugs |
03/22/2012 | WO2012037499A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol |
03/22/2012 | WO2012037490A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure |
03/22/2012 | WO2012037453A1 Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases |
03/22/2012 | US20120071865 Flowable hydrogels for control of cell in-migration |
03/22/2012 | US20120071558 Compositions of very long chain polyunsaturated fatty acids and methods of use |
03/22/2012 | US20120071550 Synergistic combinations of cartonoids and polyphenols |
03/22/2012 | US20120071542 Application of Highly Conserved Domain Sequences From Viral Genome As Template To Design Therapeutic Slirnas |
03/22/2012 | US20120071534 Lxr modulators |
03/22/2012 | US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor |